SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    P. Katsaounis, A. Kotsakis, S. Agelaki, E. Kontopodis, A. Agelidou, N. Kentepozidis, L. Vamvakas, A. Christopoulou, N. Karachaliou, D. Hatzidaki, V. Georgoulias, Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG), Cancer Chemotherapy and Pharmacology, 2015,

    CrossRef

  2. 2
    Yuka Kato, Katsuyuki Hotta, Nagio Takigawa, Naoyuki Nogami, Toshiyuki Kozuki, Akiko Sato, Eiki Ichihara, Kenichiro Kudo, Isao Oze, Masahiro Tabata, Tetsu Shinkai, Mitsune Tanimoto, Katsuyuki Kiura, Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience, Cancer Chemotherapy and Pharmacology, 2014, 73, 5, 943

    CrossRef

  3. 3
    Kenya Kanazawa, Hiroshi Yokouchi, Xintao Wang, Takashi Ishida, Yuka Fujita, Satoru Fujiuchi, Toshiyuki Harada, Masao Harada, Kei Takamura, Satoshi Oizumi, Ichiro Kinoshita, Yutaka Katsuura, Osamu Honjo, Tetsuya Kojima, Hirotoshi Dosaka-Akita, Hiroshi Isobe, Mitsuru Munakata, Masaharu Nishimura, Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902, Cancer Chemotherapy and Pharmacology, 2014, 74, 6, 1149

    CrossRef

  4. 4
    Erin M. Bertino, Tanios Bekaii-Saab, Soledad Fernandez, Robert B. Diasio, Nagla A. Karim, Gregory A. Otterson, Miguel A. Villalona-Calero, A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC), Lung Cancer, 2013, 79, 1, 27

    CrossRef

  5. 5
    Katsuyuki Hotta, Etsuji Suzuki, Massimo Di Maio, Paolo Chiodini, Yoshiro Fujiwara, Nagio Takigawa, Eiki Ichihara, Martin Reck, Christian Manegold, Lothar Pilz, Akiko Hisamoto-Sato, Masahiro Tabata, Mitsune Tanimoto, Frances A. Shepherd, Katsuyuki Kiura, Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer, Lung Cancer, 2013, 79, 1, 20

    CrossRef

  6. 6
    K. Hotta, N. Takigawa, A. Hisamoto-Sato, E. Ichihara, K. Kudo, K. Uchida, K. Yanase-Nakamura, H. Tanaka, Y. Kato, M. Tabata, M. Tanimoto, K. Kiura, Reappraisal of Short-term Low-volume Hydration in Cisplatin-based Chemotherapy: Results of a Prospective Feasibility Study in Advanced Lung Cancer in the Okayama Lung Cancer Study Group Trial 1002, Japanese Journal of Clinical Oncology, 2013, 43, 11, 1115

    CrossRef

  7. 7
    J.- C. Soria, A. Mauguen, M. Reck, A. B. Sandler, N. Saijo, D. H. Johnson, D. Burcoveanu, M. Fukuoka, B. Besse, J.- P. Pignon, Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer, Annals of Oncology, 2013, 24, 1, 20

    CrossRef

  8. 8
    Jean-Charles Soria, Tony S. Mok, Federico Cappuzzo, Pasi A. Jänne, EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects, Cancer Treatment Reviews, 2012, 38, 5, 416

    CrossRef

  9. 9
    B.E. Kiely, M. Alam, P. Blinman, M.H.N. Tattersall, M.R. Stockler, Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials, Lung Cancer, 2012, 77, 3, 537

    CrossRef

  10. 10
    Y. Fujiwara, K. Hotta, M. Di Maio, K. Kiura, N. Takigawa, M. Tabata, M. Tanimoto, Time trend in treatment-related deaths of patients with advanced non-small-cell lung cancer enrolled into phase III trials of systemic treatment, Annals of Oncology, 2011, 22, 2, 376

    CrossRef

  11. 11
    G. D'Addario, M. Fruh, M. Reck, P. Baumann, W. Klepetko, E. Felip, Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, 2010, 21, Supplement 5, v116

    CrossRef

  12. 12
    KHALID AL-SHIBLI, SAMER AL-SAAD, SIGVE ANDERSEN, TOM DONNEM, ROY M. BREMNES, LILL-TOVE BUSUND, The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma, APMIS, 2010, 118, 5
  13. 13
    Matjaz Zwitter, Viljem Kovac, Mirjana Rajer, Martina Vrankar, Uros Smrdel, Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial, Anti-Cancer Drugs, 2010, 21, 6, 662

    CrossRef

  14. 14
    Katsuyuki Hotta, Yoshiro Fujiwara, Keitaro Matsuo, Katsuyuki Kiura, Nagio Takigawa, Masahiro Tabata, Mitsune Tanimoto, Time to Progression as a Surrogate Marker for Overall Survival in Patients with Advanced Non-small Cell Lung Cancer, Journal of Thoracic Oncology, 2009, 4, 3, 311

    CrossRef

  15. 15
    Katsuyuki Hotta, Katsuyuki Kiura, Nagio Takigawa, Yoshiro Fujiwara, Masahiro Tabata, Hiroshi Ueoka, Mitsune Tanimoto, Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancer, Lung Cancer, 2008, 62, 2, 236

    CrossRef

  16. 16
    Chia-Hsuin Chang, Kuan-Yu Chen, Yinong Young-Xu, Tobias Kurth, E. John Orav, Pan-Chyr Yang, K. Arnold Chan, The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: A meta-analysis, Lung Cancer, 2008, 62, 2, 242

    CrossRef

  17. 17
    Katsuyuki Hotta, Yoshiro Fujiwara, Keitaro Matsuo, Author reply to recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy, Cancer, 2007, 110, 11
  18. 18
    Alessandra Bearz, Diego Serraino, Lucia Fratino, Massimiliano Berretta, Umberto Tirelli, Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy, Cancer, 2007, 110, 11